جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

3 مُخرَج نتائج البحث عن «Immunogenicity»

مقالوصول مفتوح2026

Efficacy and long-term impact of HPV vaccination strategies: A Scoping review of clinical trials and follow-up studies

Pharmacy Practice · مجلد 23 (4) · 1-6

Background: Human papillomavirus (HPV) is a leading cause of cervical cancer and other HPV-related cancers globally. Vaccination against HPV has proven to be a pivotal intervention in reducing the burden of these diseases. However, questions remain regarding long-term efficacy, dosing strategies, and real-world outcomes of HPV vaccines. Objective: We aim to synthesise evidence from randomised controlled trials and long-term follow-up studies on the efficacy, immunogenicity, safety, and real-world impact of HPV vaccines. Methodology: A comprehensive search was conducted in PubMed, Cochrane Library, Embase, Scopus, and Web of Science for studies published in English from 2019 to 2024. Eligible studies included randomised controlled trials and long-term follow-up analyses focusing on HPV vaccine efficacy, dosing regimens, and population-specific outcomes. Data were extracted and synthesised narratively, with findings organised into five thematic areas. Results: Seventeen studies met the inclusion criteria. Findings confirm the high efficacy of HPV vaccines in preventing HPV-related cancers and precancers, with durable immunogenicity observed up to 12 years post-vaccination. Evidence supports the potential of single-dose regimens, which could improve accessibility in resource-limited settings. Real-world data demonstrated significant reductions in HPV-related diseases across diverse populations, reinforcing the global impact of HPV vaccination programs. Conclusion: This review highlights the critical role of HPV vaccines in reducing the burden of HPV-related cancers, with robust efficacy, long-term protection, and favourable safety profiles. The findings underscore the need for continued research into optimised vaccination strategies and the expansion of global vaccination efforts.

HPV vaccinationhuman papillomaviruscervical cancer preventionHPV-associated cancers
مقالمفتوح (مستودع)20251استشهاد· Semantic Scholar

Small Interfering RNAs in Neurodegenerative Diseases: A Therapeutic Horizon

Advanced Health Science and Technology Journal · مجلد 1 (1) · 9-22

Abstract Neurodegenerative diseases (NDDs) pose a significant global health challenge, causing progressive neuronal loss and debilitating impairments. While current treatments offer only symptomatic relief, small interfering RNAs (siRNAs) have emerged as a promising therapeutic modality. This systematic review analyzed the literature (2000-2025) from different databases on siRNA therapy for NDDs, focusing on mechanisms, delivery approaches, therapeutic efficacy, and safety profiles to provide an integrated, evidence-based synthesis. The siRNA precise sequence specificity allows them to silence disease-related genes, addressing the root causes of these disorders. This review examines the fundamental biology of siRNAs, including advancements in their design, chemical modification, and innovative strategies to overcome the blood–brain barrier (BBB) for central nervous system delivery. We detail siRNA-based therapeutic strategies for major NDDs – Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis – highlighting the transition from preclinical successes to clinical trials. Despite challenges in delivery and immunogenicity, the precision of siRNA-mediated gene silencing positions this technology at the forefront of efforts to develop disease-modifying treatments, paving the way for a new era of personalized neurotherapeutics.

siRNAneurodegenerative diseasessiRNA therapeuticsgene silencing
مقالوصول مفتوح202210استشهاد· Semantic Scholar

Immunological characterization of the chemically prepared ghosts of Salmonella Typhimurium as a vaccine candidate

BMC Veterinary Research · مجلد 18 (1) · 72-72

BACKGROUND: Bacterial ghosts are the evacuated bacterial cellular membranes from most of the genetic and protein contents which preserved their surface characters. Recently, bacterial ghosts exploited for different biomedical applications, for instance, vaccination. The purpose of this study is to measure the immunogenic protective response of bacterial ghosts of Salmonella Typhimurium in animals and to allow future testing this response in humans. The immunologic response was qualitatively, quantitatively, and functionally measured. We have measured the humoral and cellular immune responses, such as immunoglobulins elevation (IgG), increased granulocytes, serum antibacterial activity, clearance of virulence in feces and liver, and the survival rate. RESULTS: The bacterial ghosts' vaccine was able to protect 100% of subcutaneously vaccinated rats and 75% of adjuvant subcutaneously vaccinated rats. The lowest survival rate was in the orally vaccinated group (25%). The maximum level of serum IgG titers, as well as serum and feces bactericidal activity (100% eradication), was exhibited in the subcutaneously vaccinated group with adjuvant vaccines followed by the subcutaneously vaccinated one. Additionally, the highest granulocytes' number was observed in the adjuvant vaccine subcutaneously immunized group. The bacterial load in liver homogenate was eliminated in the subcutaneously vaccinated rats after the virulence challenge. CONCLUSIONS: The bacterial ghosts of Salmonella enterica serovar Typhimurium that prepared by Tween 80 Protocol showed an effective vaccine candidate that protected animals, eliminated the virulence in feces and liver. These findings show that chemically induced bacterial ghosts of Salmonella Typhimurium can be a promising vaccine.

bacterial ghostsSalmonella typhimuriumvaccine candidateimmunogenicity